Pacific Biosciences (PACB) announced Monday morning that it has released a major upgrade to its PacBio RS system, including new chemistry, enhanced SMRT Cells and upgraded software.
Shares of Pacific Biosciences have been rising since the open Monday and are now up 0.76 at $5.23 on above average volume. The stock has broken out of a 2 1/2 week range and has set over a 4 1/2 month high.
For comments and feedback: editorial@rttnews.com